Scpharmaceuticals Inc
General ticker "SCPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $159.6M
Scpharmaceuticals Inc does not follow the US Stock Market performance with the rate: -20.3%.
Estimated limits based on current volatility of 3.0%: low 3.24$, high 3.44$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.52$, 7.62$]
- 2024-12-30 to 2025-12-30 estimated range: [2.72$, 6.17$]
Financial Metrics affecting the SCPH estimates:
- Negative: Non-GAAP EPS, $ of -1.40 <= 0.10
- Negative: Operating profit margin, % of -80.30 <= 1.03
- Negative: Operating cash flow per share per price, % of -21.12 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Positive: Inventory ratio change, % of -60.59 <= -1.03
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term SCPH quotes
Long-term SCPH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $13.59MM |
| Operating Expenses | $25.82MM | $36.16MM | $68.99MM |
| Operating Income | $-25.82MM | $-36.16MM | $-55.40MM |
| Non-Operating Income | $-2.21MM | $-0.68MM | $0.59MM |
| Interest Expense | $2.58MM | $3.30MM | $8.12MM |
| R&D Expense | $16.04MM | $15.53MM | $11.81MM |
| Income(Loss) | $-28.03MM | $-36.84MM | $-54.81MM |
| Profit(Loss) | $-28.03MM | $-36.84MM | $-54.81MM |
| Stockholders Equity | $56.47MM | $72.43MM | $37.22MM |
| Inventory | $0.00MM | $1.23MM | $8.84MM |
| Assets | $79.04MM | $124.19MM | $94.48MM |
| Operating Cash Flow | $-27.15MM | $-34.58MM | $-59.24MM |
| Capital expenditure | $0.01MM | $0.02MM | $0.04MM |
| Investing Cash Flow | $32.13MM | $-45.86MM | $19.96MM |
| Financing Cash Flow | $-2.53MM | $77.23MM | $14.85MM |
| Earnings Per Share* | $-1.11 | $-1.32 | $-1.42 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.